Molecular recognition of adenosine deaminase: 15N NMR studies

Nucleosides, Nucleotides and Nucleic Acids

Volumn 26, Issue 2, 2007, Pages 161-180

  Laxer, Avital ^a   Gottlieb, Hugo E ^a   Fischer, Bilha ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

15N NMR; Adenosine deaminase; Nucleosides; Purine riboside

Indexed keywords

ADENOSINE DEAMINASE; AMMONIUM CHLORIDE; AMMONIUM HYDROXIDE; NEBULARINE; NITROGEN; SODIUM NITRITE; ZINC;

ARTICLE; CATALYSIS; CRYSTALLOGRAPHY; HYDROGEN BOND; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NUCLEAR MAGNETIC RESONANCE; PH; SYNTHESIS; TITRIMETRY;

ADENOSINE DEAMINASE; MAGNETIC RESONANCE SPECTROSCOPY; NITROGEN ISOTOPES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;

EID: 33847067073     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770601112713     Document Type: Article

References (45)

1. Centelles, J.J.; Franco, R.; Bozal, J. Purification and partial characterization of brain adenosine deaminase: Inhibition by purine compounds and by drugs. J. Neurosci. Res. 1988, 19, 258-267.
2. Wiginton, D.A.; Coleman, M.S.; Hutton, J.J. Purification, characterization and radioimmunoassay of adenosine deaminase from human leukemic granulocytes. Biochem. J. 1981, 195, 389-397.
3. Kurz, L.C.; Frieden, C. Adenosine deaminase converts purine riboside into an analog of a reactive intermediate: A carbon-13 NMR and kinetic study. Biochemistry 1987, 26, 8450-8457.
4. Frick, L.; Neela, J.P.; Wolfenden, R. Transition state stabilization by deaminases: rates of nonenzymic hydrolysis of adenosine and cytidine. Bioorg. Chem. 1987, 15, 100-108.
5. Cristalli, G.; Contanzi, S.; Lambertucci, C.; Lupidi, G.; Vittori, S.; Volpini, R.; Camaioni, E. Adenosine deaminase: Functional implications and different classes of inhibitors. Med. Res. Rev. 2001, 21, 105-128.
6. Cristalli, G.; Eleuteri, A.; Vittori, S.; Volpini, R.; Camaioni, E.; Lupidi, G. Adenosine-deaminase inhibitors - structure-activity-relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogs. Drug Develop. Res. 1993, 28, 253-258.
7. Grever, M.R.; Siaw, M.F.E.; Jacob, W.F.; Niedhart, J.A.; Miser, J.S.; Coleman, M.S.; Hutton, J.J.; Balcerzak, S.P. The biochemical and clinical consequences of 2′-deoxycoformycin in refractory lymphoproliferative malignancy. Blood 1981, 57, 406-417.
8. Dhasmana, J.P.; Digerness, S.B.; Geckle, J.M.; Ng, T.C.; Glickson, J.D.; Blackstone, E.H. Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: A study utilizing the isolated rat heart adapted to 31P nuclear magnetic resonance. J. Cardiovasc. Res. 1983, 5, 1040-1047.
9. Firestein, G.S.; Bullough, D.; Erion, M.; Ugarkar, B.; Browne, G.; Barankiewicz, J.; Gruber, H.; Mullane, K. Adenosine regulating agents - A novel-approach to acute-inflammation and inflammatory arthritis. Clin. Res. 1993, 41, A170-A170.
10. Broadley, K.J. Drugs modulating adenosine receptors as potential therapeutic agents for cardiovascular diseases. Expert Opin. Therap. Pat. 2000, 10, 1669-1692.
11. Hosmane, R.S. Ring-expanded ("fat") nucleosides as broad-spectrum anticancer and antiviral agents. Curr. Topics Med. Chem. 2002, 2, 1093-1109.
12. Cristalli, G.; Eleuteri, A.; Volpini, R.; Vittori, S.; Camaioni, E.; Lupidi, G. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. J. Med. Chem. 1994, 37, 201-205.
13. Costanzi, S.; Lambertucci, C.; Volpini, R.; Vittori, S.; Lupidi, G.; Cristalli, G. 3′-deoxyribofuranose derivatives of 1-deaza and 3-deaza-adenosine and their activity as adenosine deaminase inhibitors. Nucleosides Nucleotides Nucleic Acids 2001, 20, 1037-1041.
14. Vittori, S.; Camaioni, E.; Costanzi, S.; Volpini, R.; Lupidi, G.; Cristalli, G. Structure-activity relationship of adenosine deaminase inhibitors. Nucleosides and Nucleotides 1999, 18, 741-742.
15. Sharff, A.J.; Wilson, D.K.; Chang, Z.; Quiocho, F.A. Refined 2.5 A structure of murine adenosine deaminase at pH 6.0. J. Mol. Biol. 1992, 226, 917-921.
16. Kinoshita, T.; Nishio, N.; Nakanishi, I.; Sato, A.; Fujii, T. Structure of bovine adenosine deaminase complexed with 6-hydroxy-1,6-dihydropurine riboside. Acta Cryst., Section D: Biol. Cryst. 2003, D59, 299-303.
17. Wang, Z.; Quiocho, F.A. Complexes of adenosine deaminase with two potent inhibitors: X-ray structures in four independent molecules at pH of maximum activity. Biochemistry 1998, 37, 8314-8324.
18. Sideraki, V.; Mohamedali, K.A.; Wilson, D.K.; Chang, Z.; Kellems, R.E.; Quiocho, F.A.; Rudolph, F.B. Probing the functional role of two conserved active site aspartates in mouse adenosine deaminase. Biochemistry 1996, 35, 7862-7872.
19. Deng, H.; Kurz, L.C.; Rudolph, F.B.; Callender, R. Characterization of hydrogen bonding in the complex of adenosine deaminase with a transition state analogue: a Raman spectroscopic study. Biochemistry 1998, 37, 4968-4976.
20. Frieden, C.; Kurz, L.C.; Gilbert, H.R. Adenosine deaminase and adenylate deaminase: comparative kinetic studies with transition state and ground state analog inhibitors. Biochemistry 1980, 19, 5303-5309.
21. 15N NMR spectroscopy and theoretical calculations. J. Org. Chem. 2001, 66, 5463-5481.
22. (2) malononitrile. J. Label. Comp. Radiopharm. 2000, 43, 47-53.
23. Garner, P.; Ramakanth, S. A regiocontrolled synthesis of N7- and N9-guanine nucleosides. J. Org. Chem. 1988, 53, 1294-1298.
24. Nair, V.; Richardson, S.G.; Chamberlain, S.D. 9-β-D- Ribofuranosylpurine (nebularine) and related deaminated nucleosides. A direct reductive deamination of aminopurine nucleosides. Nucleic Acids Chem. 1991, 281-285.
25. Nair, V.; Richardson, S.G. Utility of purinyl radicals in the synthesis of base-modified nucleosides and alkylpurines: 6-amino group replacement by hydrogen, chlorine, bromine, and iodine. J. Org. Chem. 1980, 45, 3969-3974.
26. Rhee, Y.; Wang, C.; Gaffney, B.L.; Jones, R.A. Nitrogen-15-labeled oligodeoxynucleotides. 6. Use of nitrogen-15 NMR to probe binding of netropsin and distamycin to {d[CGCGAATTCGCG]}2. J. Am. Chem. Soc. 1993, 115, 8742-8746.
27. 3-, ADP and ATP salts, IR investigations. Zeits. Naturforsch. Section C: Biosciences 1974, 29, 19-28.
28. Tribolet, R.; Malini-Balakrishnan, R.; Sigel, H. Ternary complexes in solution. Part 47. Influence of decreasing solvent polarity (dioxane-water mixtures) on the stability and structure of binary and ternary complexes of adenosine 5′-triphosphate and uridine 5′-triphosphate. J. Chem. Soc., Dalton Trans., Inorg. Chem. 1985, 2291-2303.
29. Markowski, V.; Sullivan, G.R.; Roberts, J.D. Nitrogen-15 nuclear magnetic resonance spectroscopy of some nucleosides and nucleotides. J. Am. Chem. Soc. 1977, 99, 714-718.
30. Buchanan, G.W.; Bell, M.J. Nitrogen-15 and mercury-199 magnetic resonance spectral investigation of inosine protonation and diamagnetic metal ion complexation. Can. J. Chem. 1983, 61, 2445-2448.
31. 15N NMR. J. Org. Chem. 2002, 67, 790-802.
32. Brown, G.B.; Weliky, V.S. The synthesis of 9-β-D-ribofuranosylpurine and the identity of nebularine. J. Biol. Chem. 1953, 204, 1019-1024.
33. Martin, R.B. Nucleoside sites for transition metal ion binding. Acc. Chem. Res. 1985, 18, 32-38.
34. Wilson, D.K.; Rudolph, F.B.; Quiocho, F.A. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science 1991, 252, 1278-1284.
35. Wilson, D.K.; Quiocho, F.A. A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water. Biochemistry 1993, 32, 1689-1693.
36. Jones, W.; Kurz, L.; Wolfenden, R. Transition state stabilization by adenosine deaminase: 1,6-addition of water to purine ribonucleoside, the enzyme's affinity for 6-hydroxy-1,6-dihydro purine ribonucleoside, and the effective concentration of substrate water at the active site. Biochemistry 1989, 28, 1242-1247.
37. Albert, A.; Armarego, W.L.F. Covalent hydration in nitrogen-containing heteroaromatic compounds. I. Qualitative aspects. Adv. Heterocycl. Chem. 1965, 4, 1-42.
38. Albert, A. Covalent hydration in nitrogen heterocycles. Adv. Heterocycl. Chem. 1976, 20, 117-143.
39. Alei, M.J.; Morgan, L.O.;Wageman, W.E. Nitrogen-15 magnetic resonance of aqueous imidazole and zinc(II)-imidazole complexes. Evidence for hexacoordination. Inorg. Chem. 1978, 17, 2288-2293.
40. Matin, G.E.; Zektzer, A.S. Two-Dimensional NMR Methods for Establishing Molecular Connectivity. VCH: Weinheim, 1988, 267-273.
41. Witanowski, M.; Stefaniak, L.;Webb, G.A. Nitrogen NMR Spectroscopy. Academic Press: New York, 1993, 14-34.
42. Remaud, G.; Welch, C.J.; Zhou, X.-X.; Chattopadhyaya, J. An assessment of electronic properties of pyrimidine and purine nucleosides by nitrogen-15 NMR spectroscopy. Nucleosides Nucleotides 1988, 7, 167-179.
43. Deng, H.; Cahill, S.; Kurz, L.; Callender, R. The assignment of downfield proton resonances in an enzyme inhibitor complex using time-dependent saturation transferred NOEs. J. Am. Chem. Soc. 2004, 126, 1952-1953.
44. 1993. Enzymes and Related Biochemicals, Worthington Biochemical Corporation, Freehold, NJ.
45. Gottlieb, H.E.; Kotlyar, V.; Nudelman, A. NMR chemical shifts of common laboratory solvents as trace impurities. J. Org. Chem. 1997, 62, 7512-7515.